Globus Medical (MEX:GMED) Cyclically Adjusted FCF per Share: MXN38.89 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:GMED Globus Medical Inc MEX:GMED
93 GF Score
Price MXN1,390.45
GF Value MXN1,744.99
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Globus Medical Cyclically Adjusted FCF per Share?

Globus Medical MEX:GMED 93 Cyclically Adjusted FCF per Share is MXN38.89 as of Mar. 2026. GuruFocus rates MEX:GMED with a GF Score™ of 93/100 and a GF Value™ of MXN1,744.99 (Modestly Undervalued). The stock has 4 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Globus Medical's adjusted free cash flow per share for the three months ended in Mar. 2026 was MXN21.237. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is MXN38.89 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Globus Medical's average Cyclically Adjusted FCF Growth Rate was 21.80% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 16.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 14.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Globus Medical was 16.00% per year. The lowest was 11.20% per year. And the median was 11.90% per year.

As of today (2026-08-01), Globus Medical's current stock price is MXN1390.45. Globus Medical's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was MXN38.89. Globus Medical's Cyclically Adjusted Price-to-FCF of today is 35.75.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Globus Medical was 77.49. The lowest was 30.09. And the median was 48.21.


Globus Medical  (MEX:GMED) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Globus Medical's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=1390.45/38.89
=35.75

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Globus Medical was 77.49. The lowest was 30.09. And the median was 48.21.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Globus Medical Cyclically Adjusted FCF per Share Related Terms


Globus Medical Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Globus Medical's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Globus Medical Cyclically Adjusted FCF per Share Chart

Globus Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 26.25 23.94 25.27 26.10 35.33

Globus Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.75 32.58 37.81 35.33 38.89

MEX:GMED vs PODD, BRKR, GKOS: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Globus Medical's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Globus Medical Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Globus Medical's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Globus Medical's Cyclically Adjusted Price-to-FCF falls into.


MEX:GMED
93GF Score
Globus Medical Inc MEX:GMED
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Globus Medical Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Globus Medical's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=21.237/330.2130*330.2130
=21.237

Current CPI (Mar. 2026) = 330.2130.

Globus Medical Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 2.396 241.018 3.283
201609 7.233 241.428 9.893
201612 2.592 241.432 3.545
201703 8.124 243.801 11.003
201706 2.300 244.955 3.101
201709 4.076 246.819 5.453
201712 6.249 246.524 8.370
201803 7.217 249.554 9.550
201806 3.576 251.989 4.686
201809 6.691 252.439 8.752
201812 5.252 251.233 6.903
201903 2.114 254.202 2.746
201906 1.486 256.143 1.916
201909 8.470 256.759 10.893
201912 7.057 256.974 9.068
202003 4.586 258.115 5.867
202006 3.104 257.797 3.976
202009 7.897 260.280 10.019
202012 12.969 260.474 16.441
202103 9.959 264.877 12.416
202106 9.773 271.696 11.878
202109 11.710 274.310 14.096
202112 11.656 278.802 13.805
202203 4.729 287.504 5.431
202206 2.567 296.311 2.861
202209 4.153 296.808 4.620
202212 8.705 296.797 9.685
202303 6.583 301.836 7.202
202306 2.890 305.109 3.128
202309 4.376 307.789 4.695
202312 10.056 306.746 10.825
202403 2.920 312.332 3.087
202406 3.539 314.175 3.720
202409 23.062 315.301 24.153
202412 28.843 315.605 30.178
202503 20.666 319.799 21.339
202506 3.628 322.561 3.714
202509 28.346 324.800 28.818
202512 26.674 324.054 27.181
202603 21.237 330.213 21.237

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of MXN38.89 mean?
Globus Medical (MEX:GMED) has a Cyclically Adjusted FCF per Share of MXN38.89 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Globus Medical and its competitors.
Is Globus Medical's Cyclically Adjusted FCF per Share too high?
Globus Medical's current Cyclically Adjusted FCF per Share is MXN38.89. Overall, Globus Medical has a GF Score™ of 93/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Globus Medical's Cyclically Adjusted FCF per Share compare to PODD and BRKR?
Globus Medical's Cyclically Adjusted FCF per Share of MXN38.89 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Globus Medical and its competitors. Globus Medical's current Cyclically Adjusted FCF per Share is MXN38.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Globus Medical stock overvalued right now?
Based on GuruFocus' analysis, Globus Medical (MEX:GMED) is currently considered Modestly Undervalued. The stock's GF Value™ is MXN1,744.99, compared to a current price of MXN1,390.45 — trading 20.3% below its estimated fair value. The current Cyclically Adjusted FCF per Share is MXN38.89. Globus Medical's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Globus Medical (MEX:GMED), the current Cyclically Adjusted FCF per Share is MXN38.89 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Globus Medical (MEX:GMED) Overvalued in 2026?

Based on GuruFocus' analysis, Globus Medical stock appears to be undervalued. The current stock price of MXN1,390.45 is trading 20.3% below its estimated GF Value™ of MXN1,744.99. GuruFocus considers Globus Medical to be Modestly Undervalued.

Key valuation signals for MEX:GMED:

  • Cyclically Adjusted FCF per Share: MXN38.89
  • GF Value™: MXN1,744.99 vs. price of MXN1,390.45 (20.3% below fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the MEX:GMED stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Globus Medical Business Description

Other Exchanges GMED:USAGM0N:Germany
Address 2560 General Armistead Avenue, Audubon, PA, USA, 19403
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.
93GF Score

Get the complete analysis for MEX:GMED

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1,390.45
Price
MXN1,744.99
GF Value